J4E Stock Overview

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada. More details

J4E fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	5/6
Financial Health	2/6
Dividends	0/6

Rewards

Trading at 95.6% below our estimate of its fair value

Earnings grew by 135.1% over the past year

Risk Analysis

Interest payments are not well covered by earnings

Highly volatile share price over the past 3 months compared to the German market

Does not have a meaningful market cap (€34M)

My Notes

Capture your thoughts, links and company narrative

MTL Cannabis Corp. Competitors

MPH Health Care

DB:93M1

€95.9m

Pierrel

DB:2FJ0

€92.8m

PharmaSGP Holding

XTRA:PSG

€299.8m

Dermapharm Holding

XTRA:DMP

€2.2b

Price History & Performance

Summary of share price highs, lows and changes for MTL Cannabis
Historical stock prices
Current Share Price	CA$0.17
52 Week High	CA$0.31
52 Week Low	CA$0.067
Beta	0
1 Month Change	70.71%
3 Month Change	109.94%
1 Year Change	-40.91%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-21.76%

Recent updates

Shareholder Returns

	J4E	DE Pharmaceuticals	DE Market
7D	18.2%	2.2%	0.7%
1Y	-40.9%	-16.8%	8.4%

Return vs Industry: J4E underperformed the German Pharmaceuticals industry which returned -16.2% over the past year.

Return vs Market: J4E underperformed the German Market which returned 8.4% over the past year.

Price Volatility

Is J4E's price volatile compared to industry and market?
J4E volatility
J4E Average Weekly Movement	25.1%
Pharmaceuticals Industry Average Movement	5.5%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	12.0%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: J4E's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: J4E's weekly volatility has decreased from 32% to 25% over the past year, but is still higher than 75% of German stocks.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Mike Perron	www.mtlcannabis.ca

MTL Cannabis Corp., through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada. The company offers dried flower, pre-rolls, and hash products. It also operates clinics that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from medical conditions.

MTL Cannabis Corp. Fundamentals Summary

How do MTL Cannabis's earnings and revenue compare to its market cap?
J4E fundamental statistics
Market cap	€22.96m
Earnings (TTM)	€1.82m
Revenue (TTM)	€50.71m

13.9x

P/E Ratio

0.5x

P/S Ratio

Is J4E overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
J4E income statement (TTM)
Revenue	CA$74.95m
Cost of Revenue	CA$28.54m
Gross Profit	CA$46.41m
Other Expenses	CA$43.72m
Earnings	CA$2.69m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.023
Gross Margin	61.92%
Net Profit Margin	3.58%
Debt/Equity Ratio	123.6%

How did J4E perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 15:41
End of Day Share Price	2025/01/02 00:00
Earnings	2024/09/30
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MTL Cannabis Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

MTL Cannabis DB:J4E Stock Report